Predstanormix Duo: A New Domestic Combination Drug for Treating Lower Urinary Tract Dysfunction Symptoms Associated with BPH

The study introduces Predstanormix Duo, a new domestic combination drug for treating lower urinary tract dysfunction symptoms associated with benign prostatic hyperplasia (BPH). This drug combines dutasteride and tamsulosin in modified-release capsules and has been shown to be bioequivalent to existing treatments. The research involved three groups of comparative clinical studies, demonstrating the drug's high safety and bioequivalence with calculated 90% confidence intervals for pharmacokinetic parameters. Predstanormix Duo is expected to enhance treatment accessibility, improve patient adherence, and offer economic benefits for long-term use.